Biotech & Pharma.T.A, Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A,

BIB 82.35

-4.5%

Jan 8 4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Jibacoa who wrote (2333)	8/19/2009 11:58:23 AM
From: Jibacoa	Read Replies (2) of 3722

CTIC continues its near term UT as it tries to go over the resistance at $1.75 to $1.90 It needs to close above that before it can retest the Jun1 H at $2.23 <g> bigcharts.marketwatch.com Although the charts at BigCharts don't show it, the H in Oct 2000 was 3,090 <g> bigcharts.marketwatch.com finance.yahoo.com On a comment at StckPreacher.com today,they said that the market for CTIC's drug candidate Pixantrone, could reach more than $1B at its 'market saturation'.<g> On Jun24, it submitted necessary paperwork for Pixantrone for treatment of non-Hodgkin's lymphoma. Brostallicin is in PII for the treatment of sarcoma. In June CTIC was included in the Russell 3000, Russell 2000, and Russell Global Indexes. In spite of its large LTD and negative CF, the ACAY is $50.But I think I will keep my 'target' at just $4, pending further developments.<g> Bernard

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next